Coronado Biosciences to Present at Upcoming Healthcare Investor Conferences
8/1/2013 9:52:16 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
BURLINGTON, Mass., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today that Dr. Harlan F. Weisman, Coronado's Chairman and CEO, will present at the following upcoming investor conferences:
Help employers find you! Check out all the jobs and post your resume.